| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |